Quentin Philippot
Inserm(FR)Université Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Bichat-Claude-Bernard(FR)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immune Cell Function and Interaction
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Inborn errors of type I IFN immunity in patients with life-threatening COVID-19(2020)2,377 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19(2021)415 cited
- → Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1(2021)300 cited
- → Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine(2021)228 cited